Improved Risk Stratification in Mycosis Fungoides and Sézary Syndrome

Дата публикации: 07-10-2026 00:00:00

Advanced-stage mycosis fungoides and Sézary syndrome (MF/SS) comprise a heterogeneous group of diseases with highly variable clinical outcomes. In an era of expanding therapeutic options, accurate prognostication may facilitate more personalized treatment strategies.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	CLIPI and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome	0	8.48	07-10-2026
2	Un nuevo paradigma del mieloma múltiple con más calidad de vida	0	6.48	05-10-2026
3	Generalized Linear Keratotic Papules in a Man in His 30s	0	6.38	30-09-2026
4	Inflation-Adjusted Medicare Reimbursement for Common Dermatologic Procedures	0	23.01	07-10-2026
5	BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus	0	28.92	30-09-2026
6	Cancer Vaccine Produces 49% Melanoma Reduction in Patients Five Years Later	0	7.96	07-06-2026
7	EADV: Autonomous AI Can Increase Clinical Capacity for Dermatologists	0	9.51	06-10-2026
8	MAIBE for Patients With Locally Advanced Pancreatic Cancer	0	5.92	01-09-2026
9	FLOT vs CROSS in Esophageal Adenocarcinoma	0	6.05	01-09-2026
10	Giant Plexiform Neurofibroma in Neurofibromatosis Type 1	0	14.65	07-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.93. Источник: archderm.jamanetwork.com.